Loading data
NSRXNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | 1.24 bn USD | 1.24 bn USD | — |
| Research and development expense | 2.24 m USD | 335 k USD | 567 k USD |
| Operating profit | -4.9 m USD | -1.08 m USD | -1.15 m USD |
| Net income (reported basis) | -5.86 m USD | -1.53 m USD | -1.05 m USD |
| Net income attributable to common shareholders | 5.86 m USD | 1.53 m USD | 1.05 m USD |
| Basic earnings per share | -0.72 USD/share | -0.22 USD/share | -0.15 USD/share |
| Diluted earnings per share | -0.72 USD/share | -0.22 USD/share | -0.2 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.